GO:0032148 activation of protein kinase B activity: Signaling Hub, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032148 (activation of protein kinase B activity) describes the biological process that switches the inactive enzyme protein kinase B (Akt/PKB) into its active, signal-transducing state.
• The canonical trigger is insulin/IGF-1 receptor signaling, which recruits PI3K and generates PIP3 to membrane-dock Akt and its upstream kinases.
• Full activation requires phosphorylation of Akt at Thr308 by PDK1 and at Ser473 by mTORC2, a two-hit mechanism that integrates growth-factor and nutrient cues.
• Once active, protein kinase B phosphorylates substrates such as p300 and downstream effectors in the PI3K/Akt/mTOR axis, controlling muscle protein synthesis, metabolism and cell survival.
• Dysregulated activation of protein kinase B activity is implicated in skeletal muscle atrophy, insulin resistance, myocardial ischemia-reperfusion injury and cancer biology.
• Experimentally, this process is dissected with phospho-specific antibodies, phosphoproteomics, kinase assays and CRISPR-engineered cell and animal models.
Description
GO:0032148, activation of protein kinase B activity, is a Gene Ontology biological process term that captures the molecular events converting the dormant enzyme protein kinase B (also known as Akt or PKB) into an active kinase. Protein kinase B is a serine/threonine kinase whose activity is switched on within minutes of growth-factor stimulation, making this process a central node in signal transduction. The term is defined as any process that initiates the activity of the inactive enzyme protein kinase B, and it is synonymous with protein kinase B activation. Because Akt sits at the crossroads of insulin action, cell growth, survival and metabolism, researchers across diabetes, cancer, muscle biology and cardiovascular science routinely measure this activation event. Understanding GO:0032148 therefore provides a mechanistic anchor for interpreting phospho-Akt signals in both physiological and pathological contexts.
activation of protein kinase B activity At A Glance
| GO ID | GO:0032148 |
|---|---|
| GO term | activation of protein kinase B activity |
| Ontology | biological_process |
| Synonym | protein kinase B activation |
| Major function | Initiates the catalytic activity of the inactive enzyme protein kinase B (Akt/PKB) in response to upstream signals such as insulin and IGF-1 |
| Upstream activators | Insulin/IGF-1 receptor, PI3K-generated PIP3, PDK1 and mTORC2 |
| Key phosphorylation sites | Thr308 (PDK1) and Ser473 (mTORC2) on Akt |
| Representative substrates | p300 and downstream PI3K/Akt/mTOR pathway effectors |
| Physiological contexts | Skeletal muscle protein synthesis, insulin action, exercise adaptation and cell survival |
What Is GO:0032148?
In plain terms, GO:0032148 describes the set of steps that turn protein kinase B from an off state into an on state. The QuickGO definition states: any process that initiates the activity of the inactive enzyme protein kinase B. This is a biological process term, not a molecular function term, because it encompasses the upstream signaling events, membrane recruitment and phosphorylation reactions that collectively initiate Akt catalytic activity. The synonym protein kinase B activation is used interchangeably in the literature.
Why Is activation of protein kinase B activity Important in Cell Biology?
Activation of protein kinase B activity is important because it is the switch that converts extracellular cues such as insulin and IGF-1 into intracellular programs for growth, survival and metabolism. This process governs muscle protein synthesis and is a target of exercise and nutritional interventions, and its dysregulation is linked to insulin resistance, muscle atrophy and myocardial injury. Because so many diseases converge on this node, measuring and manipulating GO:0032148 is a recurring experimental goal in biomedical research.
• It is the initiating event that converts inactive protein kinase B into an active kinase, making it a rate-limiting control point in growth-factor signaling.
• It integrates insulin and IGF-1 signals with downstream PI3K/Akt/mTOR outputs that drive protein synthesis.
• It is mechanistically linked to skeletal muscle atrophy and to the protective effects of exercise.
• It is associated with insulin resistance in skeletal muscle, where phosphoproteomic studies connect signaling changes to insulin action.
• It contributes to myocardial protection, as aerobic exercise modulates Akt-linked pathways to limit ischemia-reperfusion injury.
• It is targeted by bacterial effectors such as Salmonella sigD, showing that pathogens can hijack this activation process.
• It regulates transcriptional coactivators such as p300, linking kinase activation to gene expression programs.
• It is a biomarker readout (phospho-Akt) widely used to assess pathway engagement in preclinical and clinical studies.
• It is a candidate intervention node for age-associated sarcopenia and metabolic disease.
• It provides a conceptual framework for CRISPR-based dissection of upstream regulators and downstream effectors.
What Happens During activation of protein kinase B activity?
Receptor-proximal signal initiation
In simple terms: A growth factor docks onto its receptor and starts a relay that will eventually switch Akt on.
Activation of protein kinase B activity begins when insulin or IGF-1 binds its receptor tyrosine kinase, triggering receptor autophosphorylation and recruitment of adaptor and lipid kinase machinery. This receptor-proximal event is the first committed step that distinguishes the inactive from the active state of protein kinase B. In skeletal muscle, IGF-1/IGF-1R engagement is a well-documented entry point for PI3K/Akt pathway activation.
PI3K-dependent PIP3 generation and Akt membrane recruitment
In simple terms: A lipid messenger is produced that acts like a parking spot, pulling Akt to the membrane where it can be activated.
Following receptor activation, PI3K generates PIP3 at the plasma membrane, creating a docking site for pleckstrin-homology domain proteins including protein kinase B. This membrane recruitment is a prerequisite for subsequent phosphorylation events and is a defining step of GO:0032148. The process is conserved across cell types, including epithelial cells where bacterial effectors can also trigger Akt activation.
PDK1-mediated Thr308 phosphorylation
In simple terms: One kinase adds the first phosphate tag to Akt, partially turning it on.
Once at the membrane, protein kinase B is phosphorylated at Thr308 by PDK1, an event that is necessary for catalytic activity. This first phosphorylation produces a partially active enzyme and is a hallmark of the activation process. Experimental dissection of insulin and IGF-1 signaling established this step as a core component of GO:0032148.
mTORC2-mediated Ser473 phosphorylation and full activation
In simple terms: A second kinase adds a second phosphate tag, fully switching Akt on.
Full activation of protein kinase B requires a second phosphorylation at Ser473, catalyzed by mTORC2. The combination of Thr308 and Ser473 phosphorylation yields maximally active kinase capable of phosphorylating downstream substrates. This two-hit mechanism explains why phospho-Akt antibodies against both sites are used as readouts of pathway engagement.
Substrate engagement and downstream signaling
In simple terms: The active kinase now tags its target proteins, changing what the cell does.
Active protein kinase B phosphorylates substrates such as the transcriptional coactivator p300, thereby influencing gene expression programs. Downstream, the PI3K/Akt/mTOR axis controls muscle protein synthesis and is modulated by exercise and nutrition. In disease contexts, this output arm is linked to insulin resistance and myocardial injury, underscoring the functional consequences of GO:0032148.
Key Genes Involved in GO:0032148 activation of protein kinase B activity
The following genes and proteins are the principal molecular players that initiate, execute or report on activation of protein kinase B activity.
| Gene | Major Role | Research Relevance |
|---|---|---|
| AKT1 | Encodes one of the protein kinase B isoforms whose activity is initiated by GO:0032148 | Core kinase readout in insulin and growth-factor signaling studies |
| AKT2 | Protein kinase B isoform activated downstream of PI3K | Implicated in insulin action and metabolic signaling |
| AKT3 | Protein kinase B isoform contributing to the activation process | Studied in contexts where isoform-specific activation matters |
| PDK1 | Phosphorylates protein kinase B at Thr308 to initiate activity | Upstream kinase target for pathway dissection |
| MTOR | Component of mTORC2 that phosphorylates Akt at Ser473 | Central node linking nutrient and growth-factor signals |
| RICTOR | Defining subunit of mTORC2 required for Ser473 phosphorylation | Genetic handle to separate mTORC2 from mTORC1 functions |
| PIK3CA | Catalytic subunit of PI3K generating PIP3 for Akt recruitment | Frequently studied in signaling and disease models |
| PIK3R1 | Regulatory subunit of PI3K controlling pathway output | Relevant to insulin resistance and signaling studies |
| INSR | Insulin receptor initiating the upstream signal for Akt activation | Entry-point receptor in metabolic research |
| IGF1R | IGF-1 receptor that triggers PI3K/Akt activation | Target in muscle atrophy and exercise studies |
| IGF1 | Ligand that stimulates IGF-1R and downstream Akt activation | Used experimentally to induce pathway activation |
| EP300 | Transcriptional coactivator phosphorylated by active protein kinase B | Links kinase activation to gene expression |
| MINDY1 | Connected to insulin action through phosphoproteomic analysis of skeletal muscle | Candidate gene in personalized insulin-resistance research |
| APLN | Exerkine linked to reversal of age-associated sarcopenia | Relevant to exercise and muscle biology |
| GSDME | Effector in pyroptosis modulated by aerobic exercise and Akt-linked signaling | Studied in myocardial ischemia-reperfusion injury |
| SIGD | Salmonella effector that activates Akt in epithelial cells | Pathogen-driven model of Akt activation |
How Is activation of protein kinase B activity Regulated?
Activation of protein kinase B activity is tightly regulated by the balance of upstream receptor signaling, lipid second messengers and kinase complexes. Insulin and IGF-1 receptor engagement recruits PI3K to generate PIP3, which is required for membrane docking of protein kinase B. Phosphorylation by PDK1 at Thr308 and by mTORC2 at Ser473 provides the two necessary inputs for full activity. This regulation is physiologically modulated by exercise and nutrition, which alter PI3K/Akt/mTOR signaling in skeletal muscle. Phosphoproteomic studies of skeletal muscle insulin resistance further show that the regulatory network around this process is personalized and can be rewired in disease. Pathogens such as Salmonella can also regulate the process through effector proteins like sigD.
activation of protein kinase B activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| AKT1 | Growth-factor signaling and survival biology | Knockout and point-mutation cell lines with phospho-Akt readouts |
| IGF1R | Skeletal muscle atrophy and myocardial infarction models | IGF1R knockout or knock-in mouse and cell models |
| MINDY1 | Skeletal muscle insulin resistance | CRISPR knockout in muscle cells followed by phosphoproteomics |
| GSDME | Myocardial ischemia-reperfusion injury and pyroptosis | Aerobic exercise intervention in knockout mouse models |
| APLN | Age-associated sarcopenia | Apelin overexpression or knockout models in aging muscle |
Metabolic disease and insulin resistance
Activation of protein kinase B activity is a central node in insulin action, and its dysregulation is associated with skeletal muscle insulin resistance. Personalized phosphoproteomics of skeletal muscle has linked signaling changes around this process to insulin action and identified MINDY1 as a relevant factor. Because the PI3K/Akt/mTOR axis controls muscle protein synthesis, impaired activation contributes to metabolic and muscle phenotypes.
Skeletal muscle atrophy and sarcopenia
IGF-1/IGF-1R-PI3K/Akt signaling, which includes activation of protein kinase B activity, is a mechanism through which exercise alleviates skeletal muscle atrophy. The exerkine apelin has been shown to reverse age-associated sarcopenia, highlighting the therapeutic relevance of this pathway in muscle aging. Whey protein supplementation combined with exercise has been studied for its effects on muscle protein synthesis and the AKT/mTOR pathway in healthy adults.
Cardiovascular injury and ischemia-reperfusion
Aerobic exercise inhibits GSDME-dependent myocardial cell pyroptosis to protect against ischemia-reperfusion injury, a process connected to Akt-linked survival signaling. This places activation of protein kinase B activity within the protective arm of cardiac stress responses. The same pathway is relevant to myocardial infarction models where IGF-1/IGF-1R-PI3K/Akt signaling is engaged.
Infection and host-pathogen signaling
The Salmonella typhimurium effector sigD activates Akt/protein kinase B in epithelial cells, demonstrating that pathogens can directly trigger GO:0032148. This provides a non-growth-factor route to activation and a model for studying host-pathogen signaling. It also illustrates how the process can be co-opted for microbial survival strategies.
From activation of protein kinase B activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is AKT1 required for insulin-induced protein kinase B activation? | AKT1 knockout cell line with phospho-Akt immunoblotting |
| Does loss of PDK1 docking abolish Thr308 phosphorylation? | Point-mutation knock-in of the PDK1 phosphorylation site |
| Can a tagged Akt report activation dynamics in live cells? | Tagged knock-in of AKT1 with a fluorescent or affinity tag |
| Does overexpression of IGF1 enhance muscle protein synthesis signaling? | IGF1 overexpression in muscle cells or animal models |
| Which genes modify insulin resistance in skeletal muscle? | CRISPR library screening combined with phosphoproteomics |
| Does exercise-induced protection require Akt-linked signaling? | Exercise intervention in knockout mouse models |
How to Study the activation of protein kinase B activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phospho-Akt immunoblotting | Thr308 and Ser473 phosphorylation status | Confirming activation after insulin or IGF-1 stimulation |
| In vitro kinase assay | Catalytic activity of protein kinase B | Validating that phosphorylation yields active enzyme |
| Phosphoproteomics | Global phosphorylation changes in signaling networks | Mapping regulators of insulin action in skeletal muscle |
| Exercise intervention studies | Physiological modulation of PI3K/Akt signaling | Testing whether exercise alleviates muscle atrophy |
| Nutritional supplementation trials | Effects on muscle protein synthesis and AKT/mTOR | Evaluating whey protein plus exercise interventions |
| Pathogen effector assays | Growth-factor-independent Akt activation | Studying Salmonella sigD-driven signaling |
| Cardiac injury models | Akt-linked protection against pyroptosis | Testing exercise-induced cardioprotection |
| Muscle aging models | Reversal of sarcopenia via exerkines | Evaluating apelin as a therapeutic candidate |
Phospho-specific immunoblotting and kinase assays
Because activation of protein kinase B activity is defined by phosphorylation at Thr308 and Ser473, phospho-specific antibodies are the standard readout. Kinase activity assays complement immunoblotting by measuring the catalytic output of active protein kinase B. These methods are widely used in insulin and IGF-1 stimulation experiments.
Phosphoproteomics of signaling networks
Phosphoproteomics enables unbiased mapping of the signaling network around activation of protein kinase B activity. Personalized phosphoproteomics of skeletal muscle has been used to link signaling changes to insulin resistance and exercise responses. This approach can identify novel regulators such as MINDY1.
Exercise and nutritional intervention studies
Exercise and nutritional interventions are used to modulate activation of protein kinase B activity in vivo. Aerobic and resistance exercise have been shown to alleviate skeletal muscle atrophy through IGF-1/IGF-1R-PI3K/Akt signaling. Whey protein supplementation combined with exercise has been meta-analyzed for effects on muscle protein synthesis and the AKT/mTOR pathway.
Pathogen and effector-based activation models
Bacterial effectors such as Salmonella sigD provide a tool to activate Akt in epithelial cells independently of growth factors. Such models are useful for dissecting which steps of GO:0032148 are required for activation. They also connect the process to host-pathogen interaction research.
How CRISPR Can Be Used to Study GO:0032148 activation of protein kinase B activity
Knockout
CRISPR knockout of upstream regulators such as PDK1, RICTOR or AKT isoforms allows researchers to test which components are required for activation of protein kinase B activity. Loss-of-function models can be paired with phospho-Akt readouts to determine necessity. Knockout of MINDY1 in muscle cells followed by phosphoproteomics exemplifies this strategy for insulin-resistance research.
Point Mutation
Point mutation of the Thr308 or Ser473 phosphorylation sites in AKT1 can be introduced to block specific activation steps. Such models distinguish the contributions of PDK1 versus mTORC2 to the activation process. They are valuable for dissecting the two-hit mechanism of GO:0032148.
Knock-in
Tagged knock-in of AKT1 enables live-cell tracking of protein kinase B localization and activation dynamics. Knock-in of reporter or affinity tags supports biochemical purification of active kinase complexes. These models help connect membrane recruitment to downstream substrate engagement.
Overexpression
Overexpression of IGF1 or constitutively active AKT constructs can drive activation of protein kinase B activity in cell and animal models. Such models are used to test whether enhanced signaling is sufficient to protect against muscle atrophy or cardiac injury. Overexpression studies complement loss-of-function approaches to establish causality.
How EDITGENE Supports activation of protein kinase B activity Research
Researchers studying activation of protein kinase B activity-related genes often need to determine whether a candidate gene is causally involved in initiating or propagating the activation process, rather than merely correlating with it. Establishing causality requires precise genetic perturbation, ideally at the endogenous locus, combined with quantitative readouts of phospho-Akt and downstream signaling. EDITGENE provides the CRISPR tools and bioinformatics support to build such models efficiently.
Contact EDITGENE today to design your custom CRISPR model for activation of protein kinase B activity research.
Frequently Asked Questions About activation of protein kinase B activity
What is GO:0032148 activation of protein kinase B activity?
GO:0032148 is a Gene Ontology biological process term defined as any process that initiates the activity of the inactive enzyme protein kinase B, also known as Akt or PKB.
What genes are involved in activation of protein kinase B activity?
Key genes include AKT1, AKT2, AKT3, PDK1, MTOR, RICTOR, PIK3CA, PIK3R1, INSR and IGF1R, which together initiate and execute the activation process.
How is protein kinase B activated by insulin and IGF-1?
Insulin or IGF-1 binding recruits PI3K to generate PIP3, which membrane-docks protein kinase B for phosphorylation at Thr308 by PDK1 and Ser473 by mTORC2.
What are the phosphorylation sites required for protein kinase B activation?
Thr308, phosphorylated by PDK1, and Ser473, phosphorylated by mTORC2, are the two key sites required for full activation.
Why is activation of protein kinase B activity important in skeletal muscle?
It controls muscle protein synthesis through the PI3K/Akt/mTOR axis and is modulated by exercise and nutrition, with relevance to atrophy and sarcopenia.
Is activation of protein kinase B activity linked to insulin resistance?
Yes, phosphoproteomic studies of skeletal muscle have connected signaling changes around this process to insulin resistance and identified MINDY1 as a relevant factor.
Can pathogens activate protein kinase B?
Yes, the Salmonella typhimurium effector sigD activates Akt/protein kinase B in epithelial cells, providing a growth-factor-independent route to activation.
What methods are used to measure activation of protein kinase B activity?
Common methods include phospho-Akt immunoblotting, in vitro kinase assays, phosphoproteomics and exercise or nutritional intervention studies.
How does aerobic exercise affect protein kinase B signaling in the heart?
Aerobic exercise inhibits GSDME-dependent myocardial cell pyroptosis to protect against ischemia-reperfusion injury, a process connected to Akt-linked survival signaling.
What CRISPR models are useful for studying activation of protein kinase B activity?
Knockout, point-mutation, knock-in and overexpression models targeting AKT1, PDK1, RICTOR, IGF1 and related genes are widely used to dissect the activation process.
Conclusion
GO:0032148, activation of protein kinase B activity, is a foundational biological process that converts inactive protein kinase B into an active kinase through receptor-proximal signaling, PIP3-dependent membrane recruitment and dual phosphorylation by PDK1 and mTORC2. Its outputs influence muscle protein synthesis, insulin action, cardiac protection and host-pathogen signaling, making it a recurring focus in metabolic, cardiovascular and infection research. Precise CRISPR models combined with phosphoproteomic and biochemical readouts provide the most rigorous way to establish causality within this pathway.
References
- 1. Vinel C et al.. 2018. The exerkine apelin reverses age-associated sarcopenia.. Nat Med 24(9):1360-1371 PMID: 30061698
- 2. Alessi DR et al.. 1996. Mechanism of activation of protein kinase B by insulin and IGF-1.. EMBO J 15(23):6541-51 PMID: 8978681
- 3. Feng L et al.. 2022. Aerobic exercise and resistance exercise alleviate skeletal muscle atrophy through IGF-1/IGF-1R-PI3K/Akt pathway in mice with myocardial infarction.. Am J Physiol Cell Physiol 322(2):C164-C176 PMID: 34852207
- 4. Ji X et al.. 2025. Whey Protein Supplementation Combined with Exercise on Muscle Protein Synthesis and the AKT/mTOR Pathway in Healthy Adults: A Systematic Review and Meta-Analysis.. Nutrients 17(16) PMID: 40871607
- 5. Steele-Mortimer O et al.. 2000. Activation of Akt/protein kinase B in epithelial cells by the Salmonella typhimurium effector sigD.. J Biol Chem 275(48):37718-24 PMID: 10978351
- 6. Needham EJ et al.. 2024. Personalized phosphoproteomics of skeletal muscle insulin resistance and exercise links MINDY1 to insulin action.. Cell Metab 36(12):2542-2559.e6 PMID: 39577414
- 7. Chen J et al.. 2004. Role of Akt/protein kinase B in the activity of transcriptional coactivator p300.. Cell Mol Life Sci 61(13):1675-83 PMID: 15224190
- 8. Li Y et al.. 2024. Aerobic exercise inhibits GSDME-dependent myocardial cell pyroptosis to protect ischemia-reperfusion injury.. Mol Med 30(1):273 PMID: 39719560
